Nasalferón: New Cuban Nasal Spray Approved for Respiratory Infections & COVID-19 Relief
Cuban-Developed Nasalferón Receives Full Regulatory Approval for Acute Respiratory Infections Havana, Cuba – A nasal spray developed by the Center for Genetic Engineering and Biotechnology of Cuba (CIGB), known as Nasalferón, has received full regulatory approval for the treatment of acute respiratory infections. This expands the drug’s previously granted conditional registration, which was initially for … Read more